Home

Risks

Challenges and impacts for people with migraine with regard to medication overuse headache

At EAN 2022, Henrik Schytz, Associate Professor of Neurology, Denmark Headache Center, Denmark,...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Preventive and new therapeutic strategies

Current progress in preventive and new therapeutic strategies for Alzheimer’s disease were...

Read time: 3 min

Congress highlights

From group-level significance to single-subject prediction: Using machine learning to classify and predict outcomes for individual patients

Identifying which risk factors for schizophrenia can be used as biomarkers would allow prediction...

Alzheimer's Disease

Read time: 4 min

Congress highlights

Highlights in Alzheimer’s disease research from AAN Virtual 2022

A broad range of areas within Alzheimer’s disease research were covered in the AAN Virtual...

Read time: 3 min

Congress highlights

How do psychiatric comorbidities affect migraine and its treatment?

Patients with migraine often have psychiatric comorbidities. This can affect disease severity and...

Depression, Schizophrenia

Read time: 3 min

New Approaches to Acute and Long-term Treatment of Schizophrenia

In a workshop titled ‘International Update on Acute and Long-term Treatment of Schizophrenia...

Read time: 3 min

Satellite symposium

The spectrum of medication overuse headache risk factors and treatments

What makes migraine worse? A plenary session at the AHS hybrid meeting 2022 addressed exactly this...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country